retatrutide experience Phase III study demonstrates 30% weight loss Retatrutide vs Tirzepatide: Which Weight-Loss

Over 68 weeks, with a starting dose of 2 mg escalated every 4 weeks: 9 mg dose: 26.4% average body weight reduction (29.1 kg / 64.2 lbs) 12 mg dose: 28.7% average body weight reduction (32.3 kg / 71.2 lbs) Placebo: 2.1% average body weight reduction The milestone achievements tell an even more compelling story

Jarvik, J

Oscar Moreno-Perez

Guo C, et al

48 In this study, placebo or intra-nasal PYY 3-36 was administered at a dose of 200 mcg 3 times daily or 600 mcg 3 times daily for 12 weeks

The following are guidelines for each injection site: Abdomen Inject it into the fatty tissues on either side of your navel but avoid the areas around your waistband or where the skin is damaged, bruised, tender, or scarred